Acrivon Therapeutics, Inc. ACRV
Institutional shares held
23.3 Million
0
calls
0
puts
Total value of holdings
$0
$0
calls
$0
puts
Market Cap
N/A
Institutional ownership
N/A
# of Institutions
59
We take great care to ensure that the data presented and summarized in this overview for Acrivon Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ACRV
View all-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.12MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA672KShares$00.0% of portfolio
-
Marshall Wace, LLP London, X0598KShares$00.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY405KShares$01.32% of portfolio
-
Geode Capital Management, LLC Boston, MA301KShares$00.0% of portfolio
Latest Institutional Activity in ACRV
Top Purchases
Top Sells
About ACRV
Insider Transactions at ACRV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,904
-0.86%
|
$99,520
$5.54 P/Share
|
|
Feb 14
2025
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-2.56%
|
$580
$5.42 P/Share
|
|
Feb 14
2025
|
Rasmus Holm Jorgensen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-1.64%
|
$2,170
$5.42 P/Share
|
|
Feb 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-0.58%
|
$1,085
$5.42 P/Share
|
|
Feb 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
579
-0.18%
|
$2,895
$5.42 P/Share
|
|
Feb 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,152
-1.59%
|
$185,760
$5.42 P/Share
|
|
Feb 14
2025
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
724
-1.07%
|
$3,620
$5.42 P/Share
|
|
Feb 14
2025
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
469
-2.77%
|
$2,345
$5.42 P/Share
|
|
Jan 17
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
659
-1.74%
|
$3,295
$5.78 P/Share
|
|
Nov 21
2024
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,910
-0.84%
|
$119,460
$6.44 P/Share
|
|
Nov 14
2024
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-2.32%
|
$2,814
$7.92 P/Share
|
|
Nov 14
2024
|
Rasmus Holm Jorgensen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-1.37%
|
$2,576
$7.92 P/Share
|
|
Nov 14
2024
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.48%
|
$1,288
$7.92 P/Share
|
|
Nov 14
2024
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-2.14%
|
$693
$7.92 P/Share
|
|
Nov 14
2024
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
490
-0.15%
|
$3,430
$7.92 P/Share
|
|
Nov 14
2024
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,766
-2.47%
|
$418,362
$7.92 P/Share
|
|
Nov 14
2024
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.9%
|
$4,291
$7.92 P/Share
|
|
Oct 17
2024
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-1.44%
|
$3,906
$7.87 P/Share
|
|
Oct 01
2024
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-0.73%
|
$1,704
$6.98 P/Share
|
|
Aug 21
2024
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
79,616
-3.18%
|
$716,544
$9.19 P/Share
|
Last 12 Months Summary
Buy / Acquisition
5.89M
Shares
From
3
Insiders
| Open market or private purchase | 2.35M shares |
|---|---|
| Grant, award, or other acquisition | 3.53M shares |
| Exercise of conversion of derivative security | 10K shares |
Sell / Disposition
343K
Shares
From
7
Insiders
| Payment of exercise price or tax liability | 343K shares |
|---|